Shin Yonemitsu Selected Research

Shin Yonemitsu Research Topics

Disease

7	Insulin Resistance 01/2013 - 03/2006
6	Type 2 Diabetes Mellitus (MODY) 10/2020 - 12/2011
6	Hyperglycemia 01/2015 - 07/2009
4	Diabetes Mellitus 01/2016 - 06/2012
3	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 01/2016
2	MELAS Syndrome (Syndrome, MELAS) 01/2016 - 01/2016
2	Hypertriglyceridemia 01/2013 - 03/2009
2	Hypoxia (Hypoxemia) 12/2011 - 07/2004
1	Heart Failure 10/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Inappropriate ADH Syndrome (SIADH) 01/2017
1	Stupor 01/2017
1	Cognitive Dysfunction 01/2016
1	Adenocarcinoma 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Glucagonoma 01/2015
1	Pseudohypoparathyroidism 01/2014
1	Graves Disease (Basedow Disease) 01/2014
1	Hypesthesia (Numbness) 01/2014
1	Hypoparathyroidism 01/2014
1	Muscle Cramp (Cramp) 01/2014
1	Hypophosphatemia 01/2014
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2014
1	Metabolic Diseases (Metabolic Disease) 05/2013
1	Weight Gain 01/2013
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 06/2012
1	Acidosis 01/2012
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2012
1	Acid-Base Imbalance 01/2012
1	Hypokalemia 01/2012
1	Overnutrition 12/2011
1	Anorexia 12/2011
1	Inflammation (Inflammations) 12/2011
1	Non-alcoholic Fatty Liver Disease 03/2009
1	Hyperplasia 11/2007
1	Body Weight (Weight, Body) 07/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2007
1	Dyslipidemias (Dyslipidemia) 07/2007
1	Obesity 07/2007

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 01/2016 - 07/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2004
3	Antisense OligonucleotidesIBA 05/2013 - 07/2009
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2016 - 01/2013
2	Insulin Glargine (Lantus)FDA Link 01/2016 - 01/2015
2	FructoseIBA 01/2013 - 03/2009
2	Sirtuin 1IBA 12/2011 - 07/2009
1	empagliflozinIBA 10/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2020
1	Sodium-Glucose Transport ProteinsIBA 10/2020
1	Vasopressins (Vasopressin)IBA 01/2017
1	SodiumIBA 01/2017
1	Carbon DioxideIBA 01/2017
1	Growth Differentiation Factor 15IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Liraglutide FDA Link 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	Leu Transfer RNAIBA 01/2016
1	Sulfonylurea ReceptorsIBA 01/2015
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2015
1	LigandsIBA 01/2015
1	Thyroglobulin FDA Link 01/2015
1	mitiglinideIBA 01/2015
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2014
1	Parathyroid Hormone (Parathormone)IBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	TabletsIBA 01/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2014
1	GlucocorticoidsIBA 01/2013
1	Exenatide (Byetta)FDA Link 01/2013
1	LipidsIBA 01/2013
1	Proton Pumps (Proton Pump)IBA 01/2012
1	Proton Pump InhibitorsIBA 01/2012
1	ElectrolytesIBA 01/2012
1	Histones (Histone)IBA 12/2011
1	C-PeptideIBA 12/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2011
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 12/2009
1	Fructose-BisphosphataseIBA 07/2009
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 07/2009
1	phosphoenolpyruvate carboxylase kinaseIBA 07/2009
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 03/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2007
1	CorticosteroneIBA 11/2007
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2007
1	Interleukin-6 (Interleukin 6)IBA 07/2007
1	CarbohydratesIBA 07/2007
1	Triglycerides (Triacylglycerol)IBA 07/2007
1	HDL LipoproteinsIBA 07/2007
1	GlycogenIBA 07/2007
1	AdiponectinIBA 07/2007
1	Vitamin A (Retinol)FDA LinkGeneric 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007

Therapy/Procedure

4	Glycemic Control 01/2016 - 01/2013
3	Therapeutics 01/2015 - 01/2013
1	Thyroidectomy 01/2014